SONOMA PHARMACEUTICALS, INC. (SNOA) Net margin 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) net profit margin by fiscal year — reported net income divided by reported revenue.
-16.3%FY2026 · since FY2017: 72.3% → -16.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -16.3% | +7.9 pp |
| FY2025 | -24.2% | +13.8 pp |
| FY2024 | -38.0% | +0.8 pp |
| FY2023 | -38.8% | +1.5 pp |
| FY2022 | -40.3% | -19.1 pp |
| FY2021 | -21.2% | -2.8 pp |
| FY2020 | -18.5% | +43.7 pp |
| FY2019 | -62.2% | +23.8 pp |
| FY2018 | -86.0% | -158.3 pp |
| FY2017 | 72.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SNOA financial trends
SNOA RevenueSNOA Net incomeSNOA Gross profitSNOA Gross marginSNOA Operating incomeSNOA Operating marginSNOA Operating cash flowSNOA Free cash flowSNOA Capital expendituresSNOA Return on equitySNOA Stock buybacksSNOA Dividends paidSNOA Total assetsSNOA Total liabilitiesSNOA Shareholders’ equitySNOA overview →